STOCK TITAN

Precision Optics - POCI STOCK NEWS

Welcome to our dedicated page for Precision Optics news (Ticker: POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics stock.

Overview

Precision Optics Corporation (POCI) is a company that excels in the design, development, and production of advanced optical instruments. With deep expertise in high-precision optics, the company provides innovative solutions for diverse applications including medical imaging, minimally invasive surgical procedures, aerospace, and defense. By seamlessly integrating engineering excellence with tailored product design, Precision Optics has positioned itself as a reliable partner for customers requiring both standard and custom optical solutions.

Core Business Areas

At its heart, Precision Optics manufactures cutting-edge optical products that are at the forefront of technological advancement. The company focuses on:

  • Medical Optical Devices: Specializing in the development and manufacturing of endoscopes and endocouplers, the firm supports a wide range of minimally invasive diagnostic and surgical procedures. Its innovations facilitate the creation of single-use and re-usable technologies that meet stringent quality and performance standards.
  • Custom Solutions: Recognizing the unique requirements of its clients, Precision Optics excels in providing custom optical devices. This includes designing platforms and prototypes that address specific challenges in the medical, industrial, and defense sectors.
  • Industrial and Military Components: Beyond healthcare, the company supplies specialized components and assemblies tailored for industrial applications and military-grade systems, ensuring optimal performance in environments where precision is paramount.

Innovative Platforms and Technologies

One of the standout elements in the company\s portfolio is the Unity Imaging Platform. Developed through years of collaboration and research, Unity embodies a modular, adaptable architecture that accelerates the development of optical systems. By consolidating proven design elements into a flexible framework, the platform supports fast prototyping and streamlines the transition from development to production. This approach mitigates lengthy design cycles and reduces costs while upholding the highest standards of quality and compliance.

Market Position and Competitive Landscape

Operating primarily in the United States, Precision Optics has secured a solid market position through its commitment to high-quality, precision-engineered products. The company appeals to a diverse clientele ranging from medical device manufacturers to defense contractors and industrial firms. Its integrated approach—from in-house design and prototyping to mass production—ensures that it meets the varied demands of high-stakes applications. Although the competitive landscape is dynamic, Precision Optics differentiates itself with its established technical expertise, a robust engineering pipeline, and flexible solutions designed to adapt to evolving market requirements.

Operational Excellence and Quality Assurance

Precision Optics is built on a foundation of thorough research, continuous product development, and stringent quality control. The company leverages advanced micro-optics and 3D imaging technologies in its production processes. With an emphasis on a vertically integrated manufacturing model, it ensures that every stage, from the conceptual phase to final production, adheres to rigorous standards. This methodical approach not only guarantees product reliability but also enables the company to swiftly address customized client needs with targeted, robust solutions.

Industry Expertise and Customer-Centric Approach

The success of Precision Optics is underpinned by decades of experience in the optical instruments domain. Industry insights and collaborative partnerships have empowered the company to craft solutions that are both innovative and cost-effective. Its ability to rapidly transition programs from development to production highlights its responsiveness to market demands. By clearly understanding the operational hurdles in sectors like medical imaging and defense, the company provides its customers with accelerated development cycles, enhanced project efficiency, and a consistent pathway to market success.

Conclusion

Precision Optics stands as a testament to what can be achieved with innovative engineering, a meticulous approach to product development, and a commitment to quality. Its comprehensive portfolio of optical instruments, custom-design capabilities, and integrated manufacturing processes solidify its role as a key player in high-precision sectors. For those seeking comprehensive, reliable, and technologically advanced optical solutions, Precision Optics offers an in-depth blend of expertise and industry-specific innovations.

Rhea-AI Summary
Precision Optics , Inc. (POCI) will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024, and holding 1x1 meetings on May 2, 2024. Dr. Joe Forkey, CEO, and Wayne Coll, CFO, will be presenting at the conference. The presentation can be accessed via webcast on the company's website. In-person meetings can be arranged with management by contacting Planet MicroCap or Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
conferences
-
Rhea-AI Summary
Precision Optics , Inc. (NASDAQ: POCI) has announced the receipt of a $720,000 follow-on production order from a top-tier defense/aerospace customer for a new optical application. This order adds to the initial $680,000 production order received in September 2023, and $517,000 in follow-on orders in November and December 2023, bringing the total production orders for this application to over $1.9 million. The company's innovative optical assembly has met high-performance requirements, leading to multiple follow-on orders expected to be delivered by August 2024. CEO Dr. Joe Forkey expressed confidence in strong revenue growth for fiscal year 2024 and anticipated continued order volumes for the next fiscal year and beyond, signaling expansion in the defense and aerospace market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
none
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) reported Q2 2024 financial results with an 18% revenue decrease to $4.8 million, a net loss of ($758,802), and adjusted EBITDA of ($269,034). The company saw a 33% increase in engineering revenue and signed production agreements with major medical device and surgical robotics companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
Rhea-AI Summary
Precision Optics Corporation, Inc. (Nasdaq: POCI) has scheduled a conference call to discuss its second quarter of fiscal year 2024 financial results. The call will take place on Wednesday, February 14, 2024, at 5:00pm ET. Interested parties can access the call through dial-in information or a live webcast. The Company intends to release its financial results and file its 10-Q after the close of the market on the same day, followed by the conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced CEO Dr. Joe Forkey's participation in the Lytham Partners 2024 Investor Select Conference. The company will host a webcasted fireside chat and one-on-one meetings with investors. The webcast will be available for replay, and investors can arrange meetings with management via Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
conferences
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) has signed a production and technology license agreement with a leading surgical robotics company to supply a single-use endoscope assembly for their cystoscopy robotic surgery system. The agreement reflects the successful joint product development initiatives and leverages POC's unique micro-optics and digital imaging technologies. Production is set to begin at POC's facilities in the next six to twelve months, with potential transfer to the customer's or a third-party manufacturer's facilities in the future. The market for single-use medical devices is growing rapidly, and POC is well-positioned to capitalize on this trend.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
none
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced the receipt of initial purchase orders towards a $1.4 million total program development project to develop a highly complex imaging sub-assembly for a next generation ophthalmoscope for a major medical device company. The initial purchase orders amount to $170,000 towards the development budget and the program is expected to move to initial production in 18 months. The new device aims to improve access to high-quality retinal exams, crucial for early detection of diabetic retinopathy and other treatable retina-based conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
none
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced unaudited Q1 2024 operating results, revealing a 15% revenue decrease to $4.3 million. The company also reported a net loss of ($464,415) and an adjusted EBITDA of ($244,983) for the quarter. Recent highlights include a $890,000 production order for a new robotic laparoscopy system and a $680,000 production order for a defense/aerospace application.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced an $890,000 initial production order for a complex imaging sub-assembly for a new robotic laparoscopy system. The order is expected to be delivered between January and October 2024, with potential for follow-on orders depending on market acceptance. This development is anticipated to drive revenue growth and recovery in the second half of the fiscal year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
none
Rhea-AI Summary
Precision Optics Corporation, Inc. (Nasdaq: POCI) to Discuss Q1 2024 Financial Results in Upcoming Conference Call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.51%
Tags

FAQ

What is the current stock price of Precision Optics (POCI)?

The current stock price of Precision Optics (POCI) is $4.69 as of March 13, 2025.

What is the market cap of Precision Optics (POCI)?

The market cap of Precision Optics (POCI) is approximately 35.1M.

What is the core business of Precision Optics?

Precision Optics designs, develops, and manufactures advanced optical instruments, serving industries like healthcare, defense, and industrial applications through both standard and custom solutions.

Which product categories does Precision Optics offer?

The company produces a diverse array of optical devices, including endoscopes, endocouplers, and custom optical systems, along with specialized components for industrial and military use.

What is the Unity Imaging Platform?

Unity is a modular imaging platform that integrates proven design architectures to streamline the development cycle for CMOS-based and single-use optical systems in the medical sector.

How does Precision Optics generate its revenue?

Revenue is primarily driven by the production of specialized optical instruments and custom-engineered solutions, supported by strong engineering services and product development initiatives in the US market.

How does the company maintain quality across its products?

Precision Optics employs a vertically integrated manufacturing process that encompasses in-house design, prototyping, and rigorous quality control measures to uphold high standards across all products.

How does Precision Optics differentiate itself in the competitive market?

The company leverages deep technical expertise, innovative platforms like Unity, and a customer-centric approach to deliver adaptive, high-precision optical solutions that meet diverse market needs.

What markets does Precision Optics serve?

Precision Optics caters to a wide range of markets, including healthcare, defense/aerospace, and industrial sectors, by offering tailored optical solutions designed for high-performance and specialized applications.
Precision Optics

Nasdaq:POCI

POCI Rankings

POCI Stock Data

35.13M
5.92M
24.86%
32.15%
0.07%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
GARDNER